After Hours
$
3.57
Change
+0.10 +2.88%
Volume
Volume 3,630
Mar 31, 2023, 6:34 p.m.
Quotes are delayed by 20 min
Previous close
$ 3.40
$ 3.47
Change
+0.07 +2.06%
Day low
Day high
$3.37
$3.55

52 week low
52 week high
$3.37
$14.00

Market cap
$201.18M
Average volume
220,984
P/E ratio
N/A
Rev. per Employee
$31,896
EPS
-2.27
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on IPSC
-
Chardan Research initiates coverage of Century Therapeutics with a buy rating and $19 price target
-
Century Therapeutics started at overweight with $40 stock price target at J.P. Morgan
- Tomi Kilgore
-
Peter Thiel's Atai Life Sciences and 5 Other Companies List Shares
- Barron's Online
-
Century Therapeutics sets IPO terms; to offer 10.6 mln shares priced at $18 to $20 each
- Ciara Linnane
Other News on IPSC
-
10-Q: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Athersys: Is Big Pharma Sleeping At The Wheel?
- Seeking Alpha
-
Century Therapeutics (IPSC) Investor Presentation - Slideshow
- Seeking Alpha
-
10-Q: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Century Therapeutics (IPSC) Investor Presentation - Slideshow
- Seeking Alpha
-
10-Q: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Company Corporate Overview Presentation Apr 2022
- Seeking Alpha
-
What's Behind Bristol Myers Squibb's Latest Partnership?
- Motley Fool
- Loading more headlines...
Press Releases on IPSC
-
Century Therapeutics to Present at the AACR Annual Meeting 2023
- GlobeNewswire
-
Century Therapeutics to Present at Upcoming Investor Conferences
- GlobeNewswire
-
Century Therapeutics to Present at the SITC 37th Annual Meeting
- GlobeNewswire
-
Century Therapeutics to Present at Upcoming Investor Conferences
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com